Literature DB >> 27121036

Aortic root compression during transcatheter pulmonary valve replacement.

Ian Lindsay1,2, Jamil Aboulhosn1,2, Morris Salem3, Daniel Levi1,2.   

Abstract

OBJECTIVES: To describe the incidence of aortic root compression (ARC) during transcatheter pulmonary valve replacement (TPVR).
BACKGROUND: ARC can occur during balloon sizing of the right ventricular outflow tract (RVOT) or during coronary compression testing (BS/CCT) prior to TPVR, causing aortic valve dysfunction and/or root distortion with or without coronary compression. This has limited the use of TPVR in patients with native RVOTs, including those with a transannular patch (TAP). The characteristics of this patient cohort have not previously been described.
METHODS: A retrospective review was performed of all patients with congenital heart disease who presented for TPVR at UCLA from 2010 to 2015. ARC characteristics during BS/CCT were noted for all relevant cases.
RESULTS: Inclusion criteria were met by 174 patients. ARC occurred in 16 patients (9%), of whom 14 had Tetralogy of Fallot with a native/TAP RVOT (14/42, 33%, of all native/TAP patients). Five ARC patients also had concomitant coronary artery compression. Isolated coronary compression occurred in six patients. Two patients underwent successful TPVR despite ARC by implanting the valves in the distal RVOT. One patient required surgical PVR and Sapien valve explantation after TPVR caused severe ARC.
CONCLUSIONS: The majority of cases of ARC occur in patients with native/TAP RVOTs. ARC during BS/CCT may identify those at risk for ARC following TPVR. While ARC is a real phenomenon, it is unclear if it can be accurately predicted, what its clinical significance will be and how it is best avoided. Further studies are necessary to answer these questions.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  adults; complications; congenital heart disease; pediatric catheterization/intervention; pediatrics; percutaneous intervention; percutaneous valve therapy; pulmonary valve disease; transcatheter valve implantation

Mesh:

Year:  2016        PMID: 27121036     DOI: 10.1002/ccd.26547

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  9 in total

Review 1.  Utilizing Hybrid Techniques to Maximize Clinical Outcomes in Congenital Heart Disease.

Authors:  David W Bearl; Gregory A Fleming
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

Review 2.  Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.

Authors:  Mouhammad Fathallah; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2017-09-16       Impact factor: 2.931

3.  Preprocedural Risk Assessment Prior to PPVI with CMR and Cardiac CT.

Authors:  Ladonna Malone; Brian Fonseca; Thomas Fagan; Jane Gralla; Neil Wilson; Daniel Vargas; Micheal DiMaria; Uyen Truong; Lorna P Browne
Journal:  Pediatr Cardiol       Date:  2017-02-16       Impact factor: 1.655

Review 4.  Valvular heart disease in congenital heart disease: a narrative review.

Authors:  Joshua M Saef; Joanna Ghobrial
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

Review 5.  Percutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives.

Authors:  Bart W Driesen; Evangeline G Warmerdam; Gert-Jan Sieswerda; Folkert J Meijboom; Mirella M C Molenschot; Pieter A Doevendans; Gregor J Krings; Arie P J van Dijk; Michiel Voskuil
Journal:  Curr Cardiol Rev       Date:  2019

Review 6.  Pulmonary Valve Regurgitation: Neither Interventional Nor Surgery Fits All.

Authors:  Antonio F Corno
Journal:  Front Pediatr       Date:  2018-06-07       Impact factor: 3.418

7.  Trifecta St. Jude medical® aortic valve in pulmonary position.

Authors:  Antonio F Corno; Alan G Dawson; Aidan P Bolger; Branco Mimic; Suhair O Shebani; Gregory J Skinner; Simone Speggiorin
Journal:  Nano Rev Exp       Date:  2017-05-01

Review 8.  Percutaneous Pulmonary Valve Implantation.

Authors:  Luca Giugno; Alessia Faccini; Mario Carminati
Journal:  Korean Circ J       Date:  2020-04       Impact factor: 3.243

9.  Coronary Artery Anomalies and Their Impact on the Feasibility of Percutaneous Pulmonary Valve Implantation.

Authors:  Anja Hanser; Jörg Michel; Andreas Hornung; Ludger Sieverding; Michael Hofbeck
Journal:  Pediatr Cardiol       Date:  2021-08-07       Impact factor: 1.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.